ACA
MYOV

Apis Capital Advisors’s Myovant Sciences Ltd. MYOV Stock Holding History

Apis Capital Advisors’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-82,000
Closed -$1.47M – 32
2022
Q3 		$1.47M Buy
+82,000
New +$1.31M 2.21% 12
2022
Q2 		– Sell
-40,000
Closed -$533K – 33
2022
Q1 		$533K Buy
+40,000
New +$536K 0.65% 25
2021
Q1 		– Sell
-130,000
Closed -$3.59M – 53
2020
Q4 		$3.59M Buy
+130,000
New +$2.53M 3.47% 9

Other funds holding MYOV

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Apis Capital Advisors's MYOV Position: Q4 2022 in Review

Apis Capital Advisors sold out of Myovant Sciences Ltd. (MYOV) in Q4 2022, closing a stake of 82,000 shares — an estimated $1.47M sold.

Apis Capital Advisors first reported a position in MYOV in Q4 2020 and held it in 3 quarters. The position peaked at $3.59M in Q4 2020. 118 funds tracked by Wall St. Rank hold MYOV as of Q4 2022.

  • Apis Capital Advisors reported no remaining Myovant Sciences Ltd. position as of Q4 2022 after selling out during the quarter.
  • Apis Capital Advisors sold 82,000 Myovant Sciences Ltd. shares in Q4 2022, an estimated $1.47M.
  • Apis Capital Advisors first reported a position in Myovant Sciences Ltd. in Q4 2020 and held it in 3 quarters.
  • Apis Capital Advisors's Myovant Sciences Ltd. position peaked at $3.59M in Q4 2020.
  • 118 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q4 2022.

Based on Apis Capital Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.